Figure 2From: P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomasRepresentative immunostaining patterns of high-grade OSCs. Strong p53 immunoexpression (A; original magnification, × 200), negative MAPK immunoexpression (B; original magnification, × 200), positive topoII alpha immunoexpression (C; original magnification, × 200), high Ki67 proliferative activity (D; original magnification, × 200).Back to article page